Kidney outcomes and safety of sodium-glucose cotransporter-2 inhibitor therapy in autosomal dominant polycystic kidney disease: systematic review and meta-analysis.

Article B Peer reviewed Small trial

Key takeaways

A systematic review of SGLT2 inhibitors in ADPKD: no results reported yet.

Kanbay M · Mizrak B · Cig E · Karakaya E · Copur S · Covic A · Ortiz A · Mallamaci F · Zoccali C

Article · PubMed, the drug frontier · 2026 Aug 12
https://pubmed.ncbi.nlm.nih.gov/42586506/